Implantation of Autologous Selected Renal Cells in Diabetic Chronic Kidney Disease Stages 3 and 4—Clinical Experience of a “First in Human” Study
Peter Stenvinkel(Karolinska Institutet), Torbjörn Lundgren(Araim Pharmaceuticals (United States)), Randal K. Detwiler(University of North Carolina at Chapel Hill), Pontus Blomberg(Karolinska University Hospital), Jonas Wadström(Karolinska University Hospital), David A. Gerber(University of Cincinnati Medical Center), Torkel B. Brismar(Karolinska University Hospital), Tim Bertram(University College of the Cayman Islands)
Cited by 15
Related Papers
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
|Kidney International|1999|1.8k
IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly
|Kidney International|2005|927
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome)
|Nephrology Dialysis Transplantation|2000|809
Oxidative stress in end-stage renal disease: an emerging threat to patient outcome
|Nephrology Dialysis Transplantation|2003|755